Trial intelligence / Profile preview

Efficacy of Travelers' Diarrhea Vaccine System

NCT00993681Phase 3Completed

Sponsor
Intercell AG
Start
Oct 2009
Primary completion
Nov 2010
Modality
Vaccines & Immunotherapeutics
Countries
4
01

Overview

A Phase 3 trial of TD Vaccine System in traveler's diarrhea (TD), sponsored by Intercell AG. Started Oct 2009; status: completed.

02

Drugs

TD Vaccine System
03

Conditions

traveler's diarrhea (TD)

Beyond the preview

Go deeper on NCT00993681.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00993681.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call